1 min read
Add as a preferred source on Google

Lakefront Biotherapeutics Starts New €50 Million Share Buyback

The authorization took effect Nov. 16 and runs through no later than March 31, 2027. The prior €50 million program ended Oct. 16 after repurchasing about 1.99 million ordinary shares.

A blank share certificate passes through a circular opening in glass / TokenPost.ai
A blank share certificate passes through a circular opening in glass / TokenPost.ai

Lakefront Biotherapeutics NV (LKFT) began a new €50 million share repurchase authorization Nov. 16, with purchases allowed through no later than March 31, 2027, after its previous program ended.

The company completed its earlier €50 million buyback Oct. 16. That program repurchased about 1.99 million ordinary shares.

John Kim

John Kim reports on the digital-asset business for TokenPost. Send corrections or tips to info@tokenpost.com.

Loading…